Literature DB >> 11243856

Mitochondrial protein p32 can accumulate in the nucleus.

K A Brokstad1, K H Kalland, W C Russell, D A Matthews.   

Abstract

Human p32 was first isolated associated with the splicing factor ASF/SF-2. The p32 protein is translated as pre-protein from which a mitochondrial import signal is cleaved off to create the mature p32. The majority of p32 is consequently found in the mitochondria. In this study we investigated extramitochondrial p32. An increased nuclear localisation of endogenous p32 was demonstrated as a response to leptomycin B or actinomycin D treatment of cells. Mature p32 gene and deletion mutants were cloned into enhanced green fluorescence protein reporter plasmids. On transfection, EGFP-p32 protein was mainly localised to the cytoplasm and to a lesser extent to the nucleus of transfected COS cells. Upon treatment with actinomycin D or leptomycin B, the EGFP-p32 protein accumulated in the nucleus. Deletion analysis indicated which regions of EGFP-p32 are involved in nuclear export and nuclear import. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11243856     DOI: 10.1006/bbrc.2001.4473

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

1.  The trypanosome homolog of human p32 interacts with RBP16 and stimulates its gRNA binding activity.

Authors:  M L Hayman; M M Miller; D M Chandler; C C Goulah; L K Read
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

2.  The Herpesvirus Saimiri open reading frame 73 gene product interacts with the cellular protein p32.

Authors:  Kersten T Hall; Mathew S Giles; Michael A Calderwood; Delyth J Goodwin; David A Matthews; Adrian Whitehouse
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  In vitro and in vivo interactions between the hepatitis B virus protein P22 and the cellular protein gC1qR.

Authors:  S Lainé; A Thouard; J Derancourt; M Kress; D Sitterlin; J-M Rossignol
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

4.  Subcellular localization of fumarase in mammalian cells and tissues.

Authors:  Timothy Bowes; Bhag Singh; Radhey S Gupta
Journal:  Histochem Cell Biol       Date:  2006-11-17       Impact factor: 4.304

5.  An acidic protein, YBAP1, mediates the release of YB-1 from mRNA and relieves the translational repression activity of YB-1.

Authors:  Ken Matsumoto; Kimio J Tanaka; Masafumi Tsujimoto
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

6.  Localization of mitochondrial DNA encoded cytochrome c oxidase subunits I and II in rat pancreatic zymogen granules and pituitary growth hormone granules.

Authors:  Skanda K Sadacharan; Bhag Singh; Timothy Bowes; Radhey S Gupta
Journal:  Histochem Cell Biol       Date:  2005-11-03       Impact factor: 4.304

7.  Elevated expression of HABP1 is correlated with metastasis and poor survival in breast cancer patients.

Authors:  Ming Niu; Shanshan Sun; Guoqiang Zhang; Yashuang Zhao; Da Pang; Yanbo Chen
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

8.  Rev inhibition strongly affects intracellular distribution of human immunodeficiency virus type 1 RNAs.

Authors:  Dusan Cmarko; Stig-Ove Bøe; Catia Scassellati; Anne Marie Szilvay; Svend Davanger; Xiang-Dong Fu; Gunnar Haukenes; Karl-Henning Kalland; Stanislav Fakan
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  LRP130, a pentatricopeptide motif protein with a noncanonical RNA-binding domain, is bound in vivo to mitochondrial and nuclear RNAs.

Authors:  Stavroula Mili; Serafín Piñol-Roma
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

10.  Acetylated Tat regulates human immunodeficiency virus type 1 splicing through its interaction with the splicing regulator p32.

Authors:  Reem Berro; Kylene Kehn; Cynthia de la Fuente; Anne Pumfery; Richard Adair; John Wade; Anamaris M Colberg-Poley; John Hiscott; Fatah Kashanchi
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.